Affiliations 

  • 1 a Division of Physiology, School of Medical Sciences , University of Phayao , Phayao , Thailand
  • 2 b Science Laboratory Centre, Faculty of Science , Naresuan University , Phitsanulok , Thailand
  • 3 c Novel Bacteria and Drug Discovery Research Group, School of Pharmacy , Monash University Malaysia , Bandar Sunway , Malaysia
  • 4 d Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences , University of Phayao , Phayao , Thailand
  • 5 f Department of Chemistry, Faculty of Science and Center of Excellence for Innovation in Chemistry , Naresuan University , Phitsanulok , Thailand
Nat Prod Res, 2019 May;33(10):1491-1494.
PMID: 29258345 DOI: 10.1080/14786419.2017.1416386

Abstract

Azadirachta indica has long been used in traditional medicine. This study focused on isolation and characterisation of active ingredients in the extract, its fractions (NF-EA, NF-AQ, NF-G) and its effect on the cholesterol absorption activity. The NF-EA fraction was identified by marker compounds by LC-ESI-QTOF/MS. Cholesterol absorption activity was performed by measuring the solubility and size of cholesterol micelles. The intestinal motility was also examined by isolated rat's ileum to test the contraction. The extract and its fractions consist of flavonoids and phenolic compounds, like quercetin, kaempferol and myricetin. We found that A. indica extract and NF-EA increase cholesterol micelles size, while the extract, NF-AQ, myricetin and quercetin, reduced the solubility of cholesterol in micelles. The extract and quercetin inhibited the contraction induced by KCl up to 29 and 18%, respectively, and also decreased CaCl2-induced contraction. This finding is in support to traditional uses of A. indica as cholesterol-lowering agents and regulator of gastrointestinal motility.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.